In case you spent yesterday ‘getting in the zone’ for the Alabama vs. Notre Dame bowl game, and you missed the news, athenahealth announced a definitive agreement to acquire mobile app Epocrates.
Never heard of them? If you’re a doctor, that might be hard to believe. That’s because there are 330,000 of you out there who are huge fans.
So why merge the world of EHRs and mobile apps, and why now? What does this mean for current Epocrates members and athenahealth clients?
athenahealth leaders Jonathan Bush, Ed Park and Jeremy Delinsky explain:
Are you a physician who uses Epocrates? Are you just interested in mobile technology? What do you think of the news?
A couple of required disclosures regarding the video:
Regulation M-A Disclosure
In connection with the acquisition of Epocrates, Inc.(“Epocrates”) by athenahealth, Inc.(“athenahealth”) pursuant to an Agreement and Plan of Merger (the “Merger”), Epocrates will file with the U.S. Securities and Exchange Commission (the “SEC”) a proxy statement and other relevant materials in connection with the proposed transaction. Epocrates will also mail the proxy statement to Epocrates stockholders. athenahealth and Epocrates urge investors and security holders to read the proxy statement and the other relevant material when they become available because these materials will contain important information about athenahealth, Epocrates, and the proposed transaction. The proxy statement and other relevant materials (when they become available), and any and all documents filed with the SEC, may be obtained free of charge at the SEC’s web site at www.sec.gov. In addition, free copies of the documents filed with the SEC by athenahealth will be available on the “Investors” portion of athenahealth’s website at www.athenahealth.com. Free copies of the documents filed with the SEC by Epocrates will be available on the “Investor Relations” portion of Epocrates’ website at www.epocrates.com. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE OTHER RELEVANT MATERIALS WHEN THEY BECOME AVAILABLE BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE PROPOSED TRANSACTION.
athenahealth, Epocrates Merger Sub, Inc. (“MergerSub”), Epocrates, and their respective executive officers and directors may be deemed to be participants in the solicitation of proxies from the security holders of Epocrates in connection with the Merger. Information about those executive officers and directors of athenahealth is set forth in athenahealth’s proxy statement for its 2012 annual meeting of stockholders, which was filed with the SEC on April 26, 2012, and is supplemented by other public filings made, and to be made, with the SEC. Information about those executive officers and directors of Epocrates and their ownership of Epocrates common stock is set forth in Epocrates’ proxy statement for its 2012 annual meeting of stockholders, which was filed with the SEC on August 30, 2012, and is supplemented by other public filings made, and to be made, with the SEC. Investors and security holders may obtain additional information regarding the direct and indirect interests of athenahealth, MergerSub, Epocrates, and their respective executive officers and directors in the Merger by reading the proxy statement and the other filings and documents referred to above. Neither this post nor the video linked to above constitutes an offer of any securities for sale.
Safe Harbor Statement
The video linked to above contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements reflecting athenahealth, Inc. (the “Company”) management’s expectations for: consummation of the acquisition of Epocrates, Inc. and successful operational integration of the companies and their services; plans for present and future service offerings and the anticipated benefits of the companies’ those offerings; and expectations regarding market trends and market acceptance of the companies’ combined services. Such statements do not constitute guarantees of future performance, are neither promises nor guarantees, and are subject to a variety of risks and uncertainties, many of which are beyond the Company’s control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: the consummation of the transaction is subject customary closing conditions, which if not met or waived would cause the transaction not to close, including the failure to obtain approval for the transaction; failure to effectively integrate services and operations of the Company and Epocrates, Inc. in a timely manner, whether due to unforeseen hurdles or technical barriers to integration of the companies’ hardware, software, or data; failure to achieve anticipated benefits or market acceptance of integrated services; the highly competitive and rapidly changing industry in which the Company and Epocrates, Inc. operate; and the evolving and complex governmental and regulatory compliance environment in which the Company and its clients operate. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information contained in this presentation, whether as a result of new information, future events or circumstances, or otherwise. For additional disclosure regarding these and other risks faced by the Company, see the disclosures contained in its public filings with the Securities and Exchange Commission, available on the Investors section of the Company’s website at http://www.athenahealth.com and on the SEC’s website at http://www.sec.gov.